resp
Novartis’ COPD contender cleared in EU
December 4, 2009Sales and Marketing COPD, Novartis, resp
Novartis has been given a green light in the European Union to sell its Onbrez respiratory drug, allowing the firm …
GSK begins phase III COPD trials
October 28, 2009Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory
GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
MedImmune’s respiratory treatment faces US approval delay
December 3, 2008Sales and Marketing US, reg, resp
One of MedImmune's key products has hit a delay in the US, after regulators demanded further data. The FDA asked …
Spiriva partners defend drug’s safety
October 2, 2008Sales and Marketing Boehringer, COPD, Spiriva, resp
Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …
Boehringer Ingelheim outpaces market
April 14, 2008Sales and Marketing resp
Strong growth in respiratory product Spiriva once again led the way for Boehringer Ingelheim, which has just published results for …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
